(CIDRAP News) A federal vaccine advisory group meeting in Washington, DC, today unveiled a new national vaccination strategy for the next decade and reviewed the latest information on influenza vaccination in the first year of a new universal recommendation.
(CIDRAP News) Because of reports of increased fever and seizures in Australian and New Zealand children, the US government's Advisory Committee on Immunization Practices (ACIP) recommended today that a seasonal influenza vaccine made by CSL Ltd. should generally not be used in children from 6 months through 8 years old this fall and winter.
(CIDRAP News) The nation's supply of pandemic vaccine has grown to 111 million doses, enough so that the US Centers for Disease Control and Prevention (CDC) is turning part of its attention toward boosting the percentage of adults who get vaccinated.
(CIDRAP News) – A study in Australia showed that one dose of H1N1 influenza vaccine, rather than the two doses recommended in the United States, was enough to generate a probably protective immune response in children younger than 9 years.
(CIDRAP News) Despite a dip in cases, H1N1 influenza has not gone away and could resurge, making continued vaccination critical, government and private health officials said today.
Speaking on a webcast for health care providers conducted by the Department of Heath and Human Services (HHS), the experts urged healthcare workers to take the vaccine themselves and to continue to push it out to patients.
(CIDRAP News) Today was the 12th year the National Foundation for Infectious Diseases (NFID) has held a press conference to discuss its expectations for the upcoming flu season, but discussions were far from routine, reflecting uncertainty surrounding the pandemic flu strain and the complexity of launching two vaccine campaigns.
(CIDRAP News) Just as this year's early seasonal influenza immunization drive is getting under way, some vaccination providers are having trouble getting vaccine doses, the Centers for Disease Control and Prevention (CDC) reported today.
(CIDRAP News) The Rand Corp. today released its first-ever midseason survey on the uptake of the current influenza vaccine, which found that public officials still have a tall task in front of them to administer this year's record vaccine supply.
The survey indicated that about 30% of US adults had received a flu shot by mid November, but more than half of those surveyed said they didn't plan to get the immunization.